Relationship between age-related macular degeneration-associated variants of complement factor H and LOC387715 with

Jose S Pulido1, Joseph P McConnell, Ryan J Lennon

  • 1Department of Ophthalmology, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA.

Insights

Gene variants linked to age-related macular degeneration may influence coronary artery disease (CAD) risk. The complement factor H (CFH) HH variant showed a potential association with increased CAD, while LOC387715 variants may also play a role.

Area of Science:

  • Genetics and Cardiovascular Research
  • Ophthalmology and Cardiology Linkages

Background:

  • Age-related macular degeneration (AMD) is a leading cause of vision loss.
  • Coronary artery disease (CAD) is a major cause of mortality worldwide.
  • Genetic factors are implicated in both AMD and CAD, suggesting potential shared pathways.

Purpose of the Study:

  • To investigate the association between specific gene variants known to be associated with AMD and the risk of developing CAD.
  • To determine if the Y402H variant of the complement factor H (CFH) gene and the A69S variant of the LOC387715 gene locus are independently associated with CAD.

Main Methods:

  • Study included 493 patients undergoing coronary angiography.
  • Genotyping for CFH Y402H and LOC387715 A69S variants using restriction fragment length polymorphism.
  • Logistic regression analysis was employed to assess the association with CAD, adjusting for known CAD risk factors.

Main Results:

  • The CFH genotype showed a trend towards association with CAD (P=.08).
  • The CFH HH genotype (homozygous histidine variant) was associated with an increased risk of CAD (OR, 1.95; 95% CI, 1.01-3.76; P=.046).
  • The LOC387715 genotype did not show a statistically significant overall association with CAD (P=.06), but heterozygosity for the serine variant was associated with a reduced risk (OR, 0.59; 95% CI, 0.38-0.91; P=.02).

Conclusions:

  • The CFH genotype may be independently associated with CAD, particularly the HH variant.
  • The LOC387715 gene locus might also contribute to CAD risk.
  • Further research is warranted to elucidate the role of these gene variants in cardiovascular disease.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Genetic Lingo01:11

Genetic Lingo

Overview
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...